Synthesis and anticancer activity of the derivatives of marine compound rhizochalin in castration resistant prostate cancer

Sergey A. Dyshlovoy; Katharina Otte; Kseniya M. Tabakmakher; Jessica Hauschild; Tatyana N. Makarieva; Larisa K. Shubina; Sergey N. Fedorov; Carsten Bokemeyer; Valentin A. Stonik; Gunhild von Amsberg

doi:10.18632/oncotarget.24764

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Synthesis and anticancer activity of the derivatives of marine compound rhizochalin in castration resistant prostate cancer

Sergey A. Dyshlovoy _, Katharina Otte, Kseniya M. Tabakmakher, Jessica Hauschild, Tatyana N. Makarieva, Larisa K. Shubina, Sergey N. Fedorov, Carsten Bokemeyer, Valentin A. Stonik and Gunhild von Amsberg

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2018; 9:16962-16973. https://doi.org/10.18632/oncotarget.24764

Metrics: PDF 1539 views | HTML 3094 views | ?

Abstract

Sergey A. Dyshlovoy1,2,3, Katharina Otte1, Kseniya M. Tabakmakher2, Jessica Hauschild1, Tatyana N. Makarieva2, Larisa K. Shubina2, Sergey N. Fedorov2, Carsten Bokemeyer1, Valentin A. Stonik2 and Gunhild von Amsberg1

1Laboratory of Experimental Oncology, University Medical Center Hamburg-Eppendorf, Department of Oncology, Haematology and Bone Marrow Transplantation, Section Pneumology, Hubertus Wald-Tumorzentrum, Hamburg, Germany

2Laboratory of Marine Natural Products Chemistry, G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Vladivostok, Russian Federation

3School of Natural Sciences, Far Eastern Federal University, Vladivostok, Russian Federation

Correspondence to:

Sergey A. Dyshlovoy, email: [email protected]

Keywords: rhizochalin; castration resistant prostate cancer; androgen receptor; AR-V7; apoptosis

Received: December 17, 2017 Accepted: February 26, 2018 Published: March 30, 2018

ABSTRACT

Development of resistance to standard therapies complicates treatment of advanced prostate cancer. Alternative splicing variants of the androgen receptor (AR), e.g. AR-V7 can mediate resistance to AR-targeting substances abiraterone and enzalutamide. Semi-synthetic marine natural compound rhizochalinin decreases the expression of AR-V7 in human castration-resistant prostate cancer cells and thus resensitizes cells to enzalutamide.

In the current study, we modified the structure of rhizochalin in order to determine structure-activity relationships (SAR) and optimize anticancer properties. Thus, we synthesized new 18-hydroxy- and 18-aminorhizochalins and its aglycones. All compounds exhibited anticancer properties in human castration-resistant prostate cancer cells, induced apoptosis and G2/M cell cycle arrest, and were capable of autophagy inhibition. SAR analysis showed an increase of pro-apoptotic activity in the row 18-amino < 18-hydroxy < 18-keto derivatives. In general, aglycones were more cytotoxic compared to glycosides. The sugar elimination was critical for the ability to suppress AR-signaling. Rhizochalinin (2) and 18-hydroxyrhizochalinin (4) were identified as the most promising derivatives and are promoted for further development.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 24764

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

Synthesis and anticancer activity of the derivatives of marine compound rhizochalin in castration resistant prostate cancer

Abstract